comparemela.com
Home
Live Updates
Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting : comparemela.com
Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces new data from the pivotal Phase II/III...
Related Keywords
Maryland ,
United States ,
New York ,
National Institutes Of Health ,
Netherlands ,
United Kingdom ,
London ,
City Of ,
Amsterdam ,
Noord Holland ,
Dan Caley ,
Foster Mitchell Alex Shaw ,
Jim Polson ,
Anurag Relan ,
Emily Vanlare ,
Susanne Embleton ,
V Koneti Rao ,
Charlotte Cunningham Rundles ,
Davids Gottesman ,
Mount Sinai School Of Medicine ,
Nasdaq ,
Novartis ,
Exchange Commission ,
Clinical Immunology Society ,
Prnewswire Pharming Groupnv ,
European Union ,
Pharming Group ,
Lifespring Life Sciences Communication ,
Primary Immune Deficiency Clinic ,
National Institutes ,
Mount Sinai School ,
Chief Medical Officer ,
Activated Phosphoinositide ,
Orchard Therapeutics ,
Annual Report ,
Allergy Clin ,
Rev Allergy ,
Investor Relations Manager ,
Spring Life Sciences Communication ,
Pharming Groupnv ,
comparemela.com © 2020. All Rights Reserved.